Trials / Completed
CompletedNCT02486627
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
A Phase 3, Randomized, Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Meropenem Followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), Including Acute Pyelonephritis (AP), in Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 609 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a randomized, multicenter, multinational, double-blind study comparing the efficacy and safety of plazomicin compared with meropenem followed by optional oral (PO) therapy in the treatment of cUTI, including AP, in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | plazomicin | |
| DRUG | meropenem | |
| DRUG | levofloxacin (oral) |
Timeline
- Start date
- 2016-01-11
- Primary completion
- 2016-09-22
- Completion
- 2016-09-22
- First posted
- 2015-07-01
- Last updated
- 2018-08-23
- Results posted
- 2018-08-23
Source: ClinicalTrials.gov record NCT02486627. Inclusion in this directory is not an endorsement.